Globant SA (GLOB) Stock News

Rosen Law Firm is urging investors who purchased Hertz Global Holdings common stock between May 7, 2026 and June 23, 2026 to join a securities class action lawsuit before the September 22, 2026 lead plaintiff deadline. The lawsuit alleges that Hertz made materially false and misleading statements regarding its liquidity position, mischaracterizing market softness as transitory when it was actually recurring and materially depressing financial metrics, and that the company would need to undertake a dilutive, distressed capital raise.

Rosen Law Firm is encouraging investors who suffered losses exceeding $100,000 in Peabody Energy Corporation (BTU) to join a securities class action lawsuit. The lawsuit alleges that Peabody Energy provided misleading statements about its Centurion mine operations, with actual Q1 2026 output reaching only 250,000 tons versus previously estimated 700,000 tons. The lead plaintiff deadline is August 24, 2026. Similar class actions are also being pursued against ADMA Biologics and Microvast Holdings.

Rosen Law Firm is seeking lead plaintiffs for a securities class action lawsuit against PROCEPT BioRobotics Corporation. The lawsuit alleges that PROCEPT made materially false statements regarding its handpiece unit sales and revenues by utilizing an undisclosed discount program that artificially inflated sales figures. The company allegedly accumulated over 10,000 excess units in field inventory and was unable to achieve its 2025 guidance. The lead plaintiff deadline is September 22, 2026.

Rosen Law Firm is soliciting investors who purchased securities during specified periods to join class action lawsuits. The primary case involves Hertz Global Holdings, where defendants allegedly made false statements about liquidity, used-car market conditions, and financial position, leading to a dilutive capital raise that harmed shareholders. Additional class actions are mentioned for GPGI, Inc. and Alarum Technologies Ltd.

Rosen Law Firm has filed a class action lawsuit against DNOW Inc. on behalf of shareholders who held common stock as of August 5, 2025. The lawsuit alleges that defendants made false and misleading statements regarding DNOW's merger with MRC Global Inc., specifically negligently understating challenges related to MRC Global's enterprise resource planning system issues. Investors who held DNOW stock may be entitled to compensation. The deadline to serve as lead plaintiff is October 2, 2026.

Rosen Law Firm announces securities class action lawsuits against multiple companies. Verra Mobility is accused of making false statements about its relationship with Avis Budget Group and concealing material adverse facts. Hub Group and Alarum Technologies are also subjects of investigations for potential securities violations. Investors are urged to secure counsel before upcoming deadlines.

Rosen Law Firm has filed class action lawsuits against PROCEPT BioRobotics Corporation for allegedly making materially false statements regarding sales practices. The lawsuit claims PROCEPT used undisclosed discount programs to artificially inflate handpiece unit sales and revenues, created excess inventory of over 10,000 units, and provided unrealistic 2025 guidance. Investors who purchased stock between February 28, 2024 and February 25, 2026 may be eligible for compensation. The deadline to serve as lead plaintiff is September 22, 2026.

Rosen Law Firm reminds investors in Futu Holdings Limited of the August 25, 2026 lead plaintiff deadline in an ongoing securities class action. The lawsuit alleges that Futu made materially false statements regarding compliance with China Securities Regulatory Commission requirements, failed to disclose regulatory risks, and overstated financial results. Investors who purchased securities between May 24, 2023 and May 27, 2026 may be eligible for compensation.

Rosen Law Firm reminds investors of Nano-X Imaging Ltd. who purchased securities between March 31, 2025 and April 17, 2026 of the August 11, 2026 lead plaintiff deadline in an ongoing securities class action. The lawsuit alleges defendants made false statements about operational efficiency and product demand while concealing poor manufacturing alignment, increased operating expenses, and cash burn that necessitated restructuring.

A class action lawsuit has been filed against Citadel Securities LLC and Virtu Americas LLC on behalf of Genius Group Limited investors. The defendants are accused of engaging in 'spoofing'—submitting and canceling buy/sell orders without intent to execute them—to manipulate Genius stock prices and mislead market participants. The lead plaintiff deadline is August 28, 2026. Investors who purchased or sold Genius securities between April 12, 2022 and May 30, 2025 may be eligible for compensation.

Rosen Law Firm is reminding investors who purchased Microvast Holdings securities between April 1, 2025 and March 16, 2026 of an important September 21, 2026 lead plaintiff deadline in an ongoing securities class action. The lawsuit alleges that Microvast made materially false and misleading statements regarding margin targets, inventory management issues, and delays in the Huzhou Phase 3.2 expansion completion.

Rosen Law Firm is investigating potential securities claims against Barclays PLC following allegations of materially misleading business information. The investigation was triggered by reports of Barclays' £600 million exposure to failed UK mortgage lender Market Financial Solutions Ltd, which caused Barclays' stock to decline 3.99% on February 27, 2026, and an additional 2.3% on March 2, 2026. Investors who purchased Barclays securities may be eligible to join a class action lawsuit.

Rosen Law Firm is reminding investors who purchased Primoris Services Corporation stock between August 5, 2025 and June 22, 2026 of the September 21, 2026 lead plaintiff deadline in an ongoing securities class action. The lawsuit alleges that Primoris made false statements regarding its cost estimation and project oversight processes for fixed-price renewable energy projects, leading to systematic underestimation of costs and risks.

Rosen Law Firm has filed a class action lawsuit against PROCEPT BioRobotics Corporation on behalf of investors who purchased common stock between February 28, 2024 and February 25, 2026. The lawsuit alleges that PROCEPT made materially false statements regarding its handpiece unit sales and revenues by utilizing an undisclosed discount program that artificially inflated sales figures and created excess inventory of over 10,000 units. The company allegedly failed to disclose these risks and was unable to achieve its 2025 guidance. Investors must move the court by September 22, 2026 to serve as lead plaintiff.

Rosen Law Firm has filed class action lawsuits against Microvast Holdings, Inc. and other companies on behalf of investors who purchased securities during specified periods. The lawsuit alleges that Microvast made materially false and misleading statements regarding margin targets, inventory management, and the completion of facility expansions. Investors who purchased securities during the class period may be eligible for compensation.

A securities class action lawsuit has been filed against First Solar, Inc. for allegedly making materially false and misleading statements regarding its capacity to manage U.S. tariff policy impacts and overstating projected performance. The lawsuit covers purchases between February 26, 2025 and February 24, 2026. The lead plaintiff deadline is August 24, 2026.

Rosen Law Firm is notifying investors in BitGo Holdings, Inc. (NYSE: BTGO) and GRAIL, Inc. (NASDAQ: GRAL) of ongoing securities class action lawsuits. BitGo investors who purchased shares during the IPO on January 22, 2026 or between January 22 and May 13, 2026 are urged to act before the August 7, 2026 lead plaintiff deadline. The lawsuit alleges that offering documents contained false statements regarding BitGo's risk exposure to declining digital asset prices and overstated business prospects. GRAIL investors have an August 4, 2026 deadline for the class action period covering May 13, 2025 to February 19, 2026.

A securities class action lawsuit has been filed against GRAIL, Inc. for allegedly providing misleading statements about its NHS-Galleri cancer screening trial. The lawsuit claims defendants concealed material adverse facts about the trial's ability to demonstrate a reduction in Stage III-IV cancers. Investors who purchased GRAIL stock between May 13, 2025 and February 19, 2026 may be eligible for compensation. The deadline to serve as lead plaintiff is August 4, 2026.

Rosen Law Firm announces a securities class action lawsuit against Peabody Energy Corporation for allegedly providing false and misleading statements regarding its Centurion mine operations. The company significantly lowered guidance in March 2026, revealing that Q1 output would be approximately 250,000 tons instead of the previously estimated 700,000 tons due to mining commissioning challenges. Investors who purchased BTU stock between October 14, 2024 and May 4, 2026 may be eligible for compensation. The lead plaintiff deadline is August 24, 2026.

Rosen Law Firm is encouraging investors who suffered losses exceeding $100,000 in Futu Holdings Limited to join a securities class action lawsuit. The lawsuit alleges that Futu made materially false statements and failed to disclose non-compliance with China Securities Regulatory Commission requirements, including conducting securities and futures business without proper licenses. The lead plaintiff deadline is August 25, 2026.

Rosen Law Firm is notifying investors in Verra Mobility Corporation, Microsoft Corporation, and Disc Medicine, Inc. of upcoming deadlines to join securities class action lawsuits. The firm is seeking lead plaintiffs for cases involving alleged materially false statements and concealed material facts, with the primary deadline for Verra Mobility set for August 4, 2026.

A securities class action lawsuit has been filed against GPGI, Inc. (formerly CompoSecure, Inc.) for allegedly making materially false and misleading statements regarding the Husky acquisition. The lawsuit claims defendants overstated Husky's value, misrepresented revenue and EBITDA targets, and prioritized generating fees for Resolute Holdings over shareholder value. Investors who purchased Class A common stock between November 3, 2025 and May 6, 2026 may be eligible for compensation. The lead plaintiff deadline is September 14, 2026.

Rosen Law Firm announces a securities class action lawsuit against Futu Holdings Limited, alleging the company made materially false statements and failed to disclose non-compliance with China Securities Regulatory Commission requirements. The lawsuit claims Futu conducted securities, public fund sales, and futures business in mainland China without proper licenses, leading to overstated financial results. Investors who purchased securities between May 24, 2023 and May 27, 2026 may be eligible for compensation, with a lead plaintiff deadline of August 25, 2026.

Rosen Law Firm has filed class action lawsuits against Planet Fitness, Insulet Corporation, and Photronics, Inc. on behalf of investors who purchased securities during specified periods. The lawsuits allege that these companies made materially false and misleading statements regarding business metrics and financial guidance. Investors have until September 14, 2026 to move the court to serve as lead plaintiff.

Eva Live Inc. (NASDAQ: GOAI) announced a Letter of Intent to acquire a controlling 51% interest in Airbeam Wireless Technologies for approximately $16 million, with an option to acquire the remaining 49%. The acquisition provides access to over 260 patents and advanced millimeter-wave semiconductor technology built on more than $150 million in cumulative R&D investment. Eva Live aims to combine Airbeam's wireless technology with its AI platform to develop next-generation communications for autonomous drone swarms, resilient military networks, smart cities, and satellite infrastructure, targeting a $3 trillion global opportunity.

Rosen Law Firm is urging investors who purchased Nano-X Imaging Ltd. securities between March 31, 2025 and April 17, 2026 to join a class action lawsuit. The lawsuit alleges that Nano-X made false statements about operational efficiency and product demand, while concealing poor manufacturing alignment, increased operating expenses, and significant cash burn that would require disruptive restructuring measures. The lead plaintiff deadline is August 11, 2026.

Rosen Law Firm is notifying investors about multiple securities class action lawsuits. The primary focus is on Embecta Corp., where investors who purchased stock between November 25, 2025 and May 4, 2026 may be entitled to compensation. The lawsuit alleges that Embecta made false statements about its fiscal results and guidance, particularly regarding its pen needle business, which it described as 'incredibly resolute' before missing expectations and cutting 2026 guidance. The lead plaintiff deadline is August 17, 2026. Similar class actions are also mentioned for Calix, Inc. and Lucid Group, Inc.

Rosen Law Firm has filed class action lawsuits against GPGI, Inc. (formerly CompoSecure), Lucid Group, Inc., and Nano-X Imaging Ltd. on behalf of investors who suffered losses. The GPGI lawsuit alleges defendants made materially false statements regarding the Husky acquisition valuation and financial targets. Investors are encouraged to secure counsel before important deadlines.

A securities class action lawsuit has been filed against PicS N.V. following its January 2026 IPO. The lawsuit alleges that defendants made false and misleading statements regarding credit evaluation procedures, loan quality, and financial risks. Investors who purchased Class A common stock have until August 4, 2026 to serve as lead plaintiff.

Rosen Law Firm is urging investors in Black Rock Coffee Bar, Inc. (NASDAQ: BRCB) to join a securities class action lawsuit with an August 17, 2026 deadline to serve as lead plaintiff. The lawsuit alleges that defendants made materially false statements and failed to disclose that new store openings were cannibalizing existing revenue through 'sales transfer,' materially impacting financial results.